dipyridamole and arbutamine

dipyridamole has been researched along with arbutamine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (71.43)18.2507
2000's2 (28.57)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hanrath, P; Hoffmann, R; Lankes, W; Stellbrink, C1
Schröder, K1
Bergmann, K; Glatz, S; Höher, M; Kotzerke, J; Reske, SN1
Breuer, HW1
Marwick, TH1
Borges-Neto, S; Chambless, M; Coleman, RE; Joski, P; Mast, ST; Ravizzini, GC; Shaw, LK1
Samoĭlenko, LE; Sergienko, VB1

Reviews

5 review(s) available for dipyridamole and arbutamine

ArticleYear
[New diagnostic methods--ultrasound and clinico-chemical procedures in diagnosis of ischemia].
    Zeitschrift fur Kardiologie, 1993, Volume: 82 Suppl 5

    Topics: Adenosine; Cardiac Pacing, Artificial; Cardiotonic Agents; Catecholamines; Coronary Disease; Dipyridamole; Dobutamine; Echocardiography; Exercise Test; Hemodynamics; Humans; Myocardial Ischemia; Troponin; Troponin T

1993
Pharmacological stress echocardiography--practical considerations.
    British journal of clinical practice. Supplement, 1995, Volume: 82

    Topics: Cardiotonic Agents; Catecholamines; Dipyridamole; Dobutamine; Echocardiography; Heart Rate; Humans; Sensitivity and Specificity

1995
[Stress-echocardiography. The indications, methods, relevance].
    Deutsche medizinische Wochenschrift (1946), 1997, Mar-27, Volume: 122, Issue:13

    Topics: Adenosine; Cardiotonic Agents; Catecholamines; Dipyridamole; Dobutamine; Echocardiography; Exercise Test; Humans; Vasodilator Agents

1997
Current status of stress echocardiography for diagnosis and prognostic assessment of coronary artery disease.
    Coronary artery disease, 1998, Volume: 9, Issue:7

    Topics: Adenosine; Cardiotonic Agents; Catecholamines; Coronary Disease; Dipyridamole; Dobutamine; Echocardiography; Exercise Test; Humans; Sensitivity and Specificity; Vasodilator Agents

1998
[Methodological aspects of performing exercise tests used in combination with perfusion scintigraphy of the myocardium].
    Terapevticheskii arkhiv, 2001, Volume: 73, Issue:4

    Topics: Adenosine; Adrenergic beta-Agonists; Cardiomyopathies; Catecholamines; Coronary Disease; Dipyridamole; Dobutamine; Electrocardiography; Exercise Test; Heart; Heart Diseases; Humans; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents

2001

Other Studies

2 other study(ies) available for dipyridamole and arbutamine

ArticleYear
[Whole body distribution of Tc-99m-sestamibi after pharmacological stress with arbutamine and dipyridamole compared with resting conditions].
    Nuklearmedizin. Nuclear medicine, 1997, Volume: 36, Issue:1

    Topics: Adrenergic beta-Agonists; Adult; Aged; Blood Pressure; Catecholamines; Coronary Disease; Dipyridamole; Exercise Test; Female; Heart; Heart Rate; Humans; Lung; Male; Middle Aged; Myocardial Infarction; Rest; Technetium Tc 99m Sestamibi; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents

1997
Incremental prognostic value of RNA ejection fraction measurements during pharmacologic stress testing: a comparison with clinical and perfusion variables.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:6

    Topics: Adenosine; Aged; Cardiotonic Agents; Catecholamines; Coronary Circulation; Coronary Disease; Dipyridamole; Dobutamine; Female; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Radiopharmaceuticals; Stroke Volume; Survival Analysis; Technetium Tc 99m Sestamibi; Vasodilator Agents; Ventriculography, First-Pass

2001